Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
[68Ga]Ga-AKY-2519
- Development stage
- Unknown
- Lead developer
- Aktis Oncology
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Peptides
- Administration
- Intravenous
01
Overview
[68Ga]Ga-AKY-2519 is a gallium-68-labeled diagnostic radiopharmaceutical developed by Aktis Oncology. It consists of a novel miniprotein binder that specifically targets B7-H3 (CD276), a cell-surface antigen frequently overexpressed in various solid tumors, including metastatic castration-resistant prostate cancer (mCRPC). As a PET/CT imaging agent, it is used to evaluate biodistribution and tumor uptake, serving as a companion diagnostic surrogate for therapeutic radioconjugates targeting the same antigen, such as [177Lu]Lu-AKY-2519 and [225Ac]Ac-AKY-2519. Early clinical data from first-in-human studies demonstrate robust tumor uptake across multiple metastatic sites with favorable dosimetry and safety profiles.
- Other names
- 68Ga-AKY-2519gallium-68 AKY-2519gallium68 AKY-2519gallium 68 AKY-2519
02
Targets
B7-H3
Beyond the preview
Go deeper on [68Ga]Ga-AKY-2519.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on [68Ga]Ga-AKY-2519.